Delivery Order SPE2DB22D2206-SPE2DB23FGT59
- Not listed
- This federal contract award, valued at $88,164.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of Stelara 90 mg/ml syringes, a specialty medication, through May 2, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as...
- This federal contract award is for $38,945.82 and was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Stelara 90 mg/ml syringes, a specialty medication, with a completion date of December 20, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., and the contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Stelara 45 mg/0.5 ml syringes. The contract, valued at $3,281.21, is a firm fixed-price delivery order with a completion date of March 22, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract, valued at $11,121.88, is for the delivery of Stelara 45 mg/0.5 ml syringes, a specialty medication used for various medical conditions. The contract has an ultimate completion date of May 2, 2023 and is a firm fixed-price delivery order. The contract is not designated as a...
- This federal contract award, valued at $48,403.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Stelara 90 mg/ml syringes, a specialty medication. This is a firm fixed-price delivery order contract with a period of performance ending on January 31, 2024. The contract was awarded on an unrestricted, full and open competition basis with no set-aside designation. Amerisourcebergen Drug Corp is a...
- This federal contract award, valued at $16,915.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract covers the delivery of Stelara 90 mg/ml syringes, a specialty pharmaceutical product, with a completion date of February 13, 2024. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and...
- This federal contract award, valued at $7,400.33, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company and subsidiary of Cencora, Inc. The contract provides for the delivery of Stelara 90 mg/ml syringes, a specialty pharmaceutical product. The award is a delivery order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a potential value of up to $999,999,999.00 and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc. The $6,715.70 firm-fixed-price delivery order is for the supply of Stelara 90 mg/mL syringes. This award falls under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military...
- This federal contract award, issued by the Defense Logistics Agency (DLA) Troop Support Medical, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,407.76, is for the delivery of Stelara 90 mg/ml syringes. This is a firm fixed-price delivery order contract with a completion date of May 16, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp also holds a $999,999,999...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $90,052.39, is for the delivery of Stelara 90 mg/ml syringes and has a completion date of September 15, 2021. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB23FGT59Delivery Order
This federal contract award, valued at $17,328.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Stelara 90 mg/ml syringes, a specialty medication, and has an ultimate completion date of April 18, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.3k | 4/17/23 |